13F-HR filed by Essex Woodlands Management, Inc.
Essex Woodlands Management, Inc. filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 7 holding rows worth $179,342,176.
- Accession
- 0001398344-23-003145
- Filer
- CIK 1542339
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 7 entries on the cover page, a total value of $179,342,176 stated on the cover page (in dollars after the unit check, H1), rows summing to $179,342,176 with VALUE read as dollars as filed, 13F file number 028-14839. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MIMEDX GROUP INC | 602496101 | COM | 23,415,584 | $65,095,324 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 4,110,709 | $47,273,154 | dollars as filed | |
| BIOVENTUS INC | 09075A108 | COM CL A | 12,096,702 | $31,572,392 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 4,190,921 | $14,668,224 | dollars as filed | |
| VENUS CONCEPT INC | 92332W105 | COM | 31,337,856 | $10,028,114 | dollars as filed | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 457,085 | $8,437,789 | dollars as filed | |
| MEDICINOVA INC | 58468P206 | COM NEW | 1,105,941 | $2,267,179 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001398344-23-003145 | this filing | 2023-02-14 | acceptance time not in the bulk data set |